In an age of increasingly individualized healthcare, Elizabeth Philp has emerged as a significant figure of innovation, especially in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a movement to make bespoke medications more accessible, questioning the